Table 1.
Laboratory findings in blood and CSF (in the inpatient course)
| Measure (blood) | Reference range | Result |
|---|---|---|
| White blood cell count (G/L) | 4.40–11.30 | 6.7 |
| Red blood cell count (T/L) | 4.50–5.90 | 4.72 |
| Lymphocytes (%) | 10–50 | 13 |
| LDH (U/L) | < 248 | 328 |
| d-dimers (µg/l) | < 500 | 2001 |
| Myoglobin (µg/l) | 23.0–72.0 | 370.9 |
| IL-6 (pg/ml) | < 8.0 | 90.2 |
| CRP (mg/l) | < 5.0 | 93.3 |
| SARS-CoV-2-IgA antibody (indices) | < 0.8–1.0 | 10.9 |
| SARS-CoV-2-IgG antibody (indices) | < 0.8–1.0 | 13.2 |
| Measure (CSF) | Reference range | Result |
|---|---|---|
| CSF aspect | Clear | Clear |
| White blood cell count (/µl) | < 5 | 9 |
| Red blood cell count (/µl) | < 100 | < 100 |
| Monocytes (%) | 12 | |
| Lymphocytes (%) | 88 | |
| Total Proteins (mg/l) | 180–430 | 396 |
| Glucose (mg/dl) | < 75 | 57 |
| Lactate (mmol/l) | 1.70–2.60 | 1.65 |
| Isoelectrofocusing | Normal | Normal |
| Advanced virus measures (CSF) | Reference range | Result |
|---|---|---|
| DNA-PCR of Herpes Simplex Virus, Varicella-Zoster Virus, Cytomegaly and Epstein Barr Virus | Negative | Negative |
| RT-PCR for SARS-CoV-2 Virus | Negative | Negative |
| SARS-CoV-2-IgA antibody | Negative | Negative |
| SARS-CoV-2-IgG antibody | Negative | Negative |
| Measles IgG | < 1.4 | 1.1 |
| Rubella IgG | < 1.4 | 1.3 |
| Herpes Simplex Virus 1/2 IgG | < 1.4 | 1.1 |
| Varicella Zoster Virus IgG | < 1.4 | 1.1 |
| Advanced antineuronal antibody measures (serum and CSF) | ||
|---|---|---|
| GAD65, NMDA-, and GABA-B-receptor, IgLON5, AMPA-R subtype 2, DPPX, LGI1, CASPR2, Glycine-receptor, mGluR5, mGluR1, Amphiphysin, CV2/CRMP5, Ma2/Ta, Hu, Ri, Yo, Zic4, Recoverin, Sox1, Titin, DNER/Tr | Negative | Negative |